הלוואות ואשראי לטווח ארוך של החברה: GeoVax Labs Inc (GOVX)

GeoVax Labs, Inc. (GOVX) is developing DNA-based drugs and antiviral vaccines, leveraging government grants and clinical trial success. This defensive security sector remains independent of economic conditions, with risks primarily tied to scientific outcomes. The market price confirmed by the chart on GURU.Markets shows long-term debt at 0.00. Future growth will depend on the competition for funding and the interest of major funds.

Investors should employ debt stress testing to assess the resilience of the capital structure to interest rate fluctuations. The diversification of GeoVax Labs (GOVX) production sites requires stable funding; therefore, the company's long-term debt reflects the volume of funds raised for biocomponent development, providing a measure of the balance between investment growth and the risk of excessive leverage on the business.